CoChat

Protection Against Myocardial Infarction and No-Reflow Through Preservation of Vascular Integrity by Angiopoietin-Like 4

Galaup, Ariane, Gomez, Elisa, Souktani, Rachid, Durand, Mélanie, Cazes, Aurélie, Monnot, Catherine, Teillon, Jérémie, Le Jan, Sébastien, Bouleti, Claire, Briois, Gaëlle, Philippe, Josette, Pons, Sandrine, Martin, Valérie, Assaly, Rana, Bonnin, Philippe, Ratajczak, Philippe, Janin, Anne, Thurston, Gavin, Valenzuela, David M., Murphy, Andrew J., Yancopoulos, George D., Tissier, Renaud, Berdeaux, Alain, Ghaleh, Bijan, Germain, Stéphane · 2012 · Circulation
Cited by 150

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background—: Increased permeability, predominantly controlled by endothelial junction stability, is an early event in the deterioration of vascular integrity in ischemic disorders. Hemorrhage, edema, and inflammation are the main features of reperfusion injuries, as observed in acute myocardial infarction (AMI). Thus, preservation of vascular integrity is fundamental in ischemic heart disease. Angiopoietins are pivotal modulators of cell–cell junctions and vascular integrity. We hypothesized that hypoxic induction of angiopoietin-like protein 4 (ANGPTL4) might modulate vascular damage, infarct size, and no-reflow during AMI. Methods and Results—: We showed that vascular permeability, hemorrhage, edema, inflammation, and infarct severity were increased in angptl4 -deficient mice. We determined that decrease in vascular endothelial growth factor receptor 2 (VEGFR2) and VE-cadherin expression and increase in Src kinase phosphorylation downstream of VEGFR2 were accentuated after ischemia-reperfusion in the coronary microcirculation of angptl4 -deficient mice. Both events led to altered VEGFR2/VE-cadherin complexes and to disrupted adherens junctions in the endothelial cells of angptl4 -deficient mice that correlated with increased no-reflow. In vivo injection of recombinant human ANGPTL4 protected VEGF-driven dissociation of the VEGFR2/VE-cadherin complex, reduced myocardial infarct size, and the extent of no-reflow in mice and rabbits. Conclusions—: These data showed that ANGPTL4 might constitute a relevant target for therapeutic vasculoprotection aimed at counteracting the effects of VEGF, thus being crucial for preventing no-reflow and conferring secondary cardioprotection during AMI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.111.049072

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 150

Metadata

Authors
Galaup, A., Gomez, E., Souktani, R., Durand, M., Cazes, A., Monnot, C., Teillon, J., Le Jan, S., Bouleti, C., Briois, G., Philippe, J., Pons, S., Martin, V., Assaly, R., Bonnin, P., Ratajczak, P., Janin, A., Thurston, G., Valenzuela, D. M., Murphy, A. J., Yancopoulos, G. D., Tissier, R., Berdeaux, A., Ghaleh, B., & Germain, S.
Venue
Circulation
Published
2012-01
Volume
125
Issue
1
Pages
140-149
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2068235733
Cited by
150
References
6
FWCI
7.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protection Against Myocardial Infarction and No-Reflow Through Preservation of Vascular Integrity by Angiopoietin-Like 4. https://app.cochat.ai/papers/10.1161/circulationaha.111.049072
The paper
Galaup, A., Gomez, E., Souktani, R., Durand, M., Cazes, A., Monnot, C., Teillon, J., Le Jan, S., Bouleti, C., Briois, G., Philippe, J., Pons, S., Martin, V., Assaly, R., Bonnin, P., Ratajczak, P., Janin, A., Thurston, G., Valenzuela, D. M., . . . Germain, S. (2012). Protection Against Myocardial Infarction and No-Reflow Through Preservation of Vascular Integrity by Angiopoietin-Like 4. Circulation. https://doi.org/10.1161/circulationaha.111.049072

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.